Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Tervaert

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Kidney International|June 9, 2000
Antiproteinase 3- and antimyeloperoxidase-associated vasculitisC F Franssen, C A Stegeman, C G Kallenberg, et al.
Kidney International|January 3, 2001
Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptidesY M Van Der Geld, A Simpelaar, R Van Der Zee, et al.
Lancet (London, England)|September 22, 1990
Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titreJ W Tervaert, M G Huitema, R J Hené, et al.
Arthritis and Rheumatism|October 3, 2000
Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective studyM M Boomsma, C A Stegeman, M J van der Leij, et al.
The Netherlands Journal of Medicine|October 6, 1999
The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatmentJ W Haveman, A C Muller Kobold, J W Tervaert, et al.
Journal of the American Society of Nephrology : JASN|October 17, 1998
Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritisC F Franssen, C A Stegeman, W W Oost-Kort, et al.
Clinical and Experimental Immunology|May 22, 2001
Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteersJ W Fijen, J G Zijlstra, P De Boer, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 1999
Antimyeloperoxidase-associated lung disease. An experimental modelP Foucher, P Heeringa, A H Petersen, et al.
The Journal of Pathology|February 17, 2001
Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosisP Heeringa, M Bijl, A de Jager-Krikken, et al.
The Netherlands Journal of Medicine|April 1, 1990
Different immunological specificities and disease associations of c-ANCA and p-ANCAR Goldschmeding, J W Tervaert, R O Gans, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Kidney International|June 9, 2000
Antiproteinase 3- and antimyeloperoxidase-associated vasculitisC F Franssen, C A Stegeman, C G Kallenberg, et al.
Kidney International|January 3, 2001
Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptidesY M Van Der Geld, A Simpelaar, R Van Der Zee, et al.
Lancet (London, England)|September 22, 1990
Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titreJ W Tervaert, M G Huitema, R J Hené, et al.
Arthritis and Rheumatism|October 3, 2000
Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective studyM M Boomsma, C A Stegeman, M J van der Leij, et al.
The Netherlands Journal of Medicine|October 6, 1999
The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatmentJ W Haveman, A C Muller Kobold, J W Tervaert, et al.
Journal of the American Society of Nephrology : JASN|October 17, 1998
Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritisC F Franssen, C A Stegeman, W W Oost-Kort, et al.
Clinical and Experimental Immunology|May 22, 2001
Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteersJ W Fijen, J G Zijlstra, P De Boer, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 1999
Antimyeloperoxidase-associated lung disease. An experimental modelP Foucher, P Heeringa, A H Petersen, et al.
The Journal of Pathology|February 17, 2001
Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosisP Heeringa, M Bijl, A de Jager-Krikken, et al.
The Netherlands Journal of Medicine|April 1, 1990
Different immunological specificities and disease associations of c-ANCA and p-ANCAR Goldschmeding, J W Tervaert, R O Gans, et al.
Pageof 10